Target Name: REM1
NCBI ID: G28954
Review Report on REM1 Target / Biomarker Content of Review Report on REM1 Target / Biomarker
REM1
Other Name(s): RAS (RAD and GEM)-like GTP-binding 1 | GD:REM | REM | RRAD and GEM like GTPase 1 | GTP-binding protein REM 1 | GTPase GES | OTTHUMP00000030521 | MGC48669 | REM1_HUMAN | Rad and Gem-like GTP-binding protein 1 | GES | GTPase-regulating endothelial cell sprouting

Guanosine-triphosphate (GTP) and Its Role in The RAS/GTP Signaling Pathway

Guanosine-triphosphate (GTP) is a key intracellular signaling molecule that plays a vital role in various cellular processes. It is a nucleotide base that is derived from guanine, which is a crucial molecule in purine metabolism. GTP is a powerful adaptable molecule that can bind to various protein-protein interaction sites, including those of the RAS (RAD and GEM) family. The RAS/GTP signaling pathway is a critical pathway that regulates various cellular processes, including cell growth, differentiation, and survival. REM1 (RAS- like GTP-binding 1) is a protein that belongs to the RAS/GTP signaling pathway. In this article, we will discuss the biology of REM1, its potential as a drug target, and the research that has been done on it.

History of REM1

REM1 was first identified in the 1990s as a protein that interacts with the RAS GTPase. It is a 21-kDa protein that contains a N-terminal region that is similar to the N-terminus of the RAS protein. It also has a C- terminal region that is similar to the C-terminus of the GTPase. The structure of REM1 has been determined using X-ray crystallography, and it has a unique fold that is similar to that of other RAS-like proteins.

Function of REM1

REM1 is a critical component of the RAS/GTP signaling pathway. It functions as a GTPase-activating protein (GAP) by activating the RAS GTPase. The RAS GTPase is a protein that plays a vital role in regulating various cellular processes, including cell growth , differentiation, and survival. It is a nucleotide base that is derived from the amino acid cysteine, and it has a critical role in the regulation of protein-protein interactions. The RAS GTPase can bind to various protein-protein interaction sites, including those of the REM1 protein.

REM1 has been shown to play a critical role in the regulation of cellular processes, including cell growth, differentiation, and survival. It has been shown to interact with various proteins, including the RAS protein, the protein p110, and the protein kinase PDK4. It has also been shown to play a critical role in the regulation of cellular signaling pathways, including the regulation of cell proliferation, the regulation of cell survival, and the regulation of cell differentiation.

Potential as a Drug Target

REM1 has the potential to be a drug target due to its unique function as a GAP and its role in the regulation of cellular processes. GAPs are proteins that can activate protein kinases, and they have been shown to play a critical role in the regulation of various cellular processes. Activating GAPs can lead to the regulation of protein-protein interactions and the regulation of cellular signaling pathways.

REM1 has been shown to interact with various proteins, including the RAS protein, the protein p110, and the protein kinase PDK4. It has also been shown to play a critical role in the regulation of cellular signaling pathways, including the regulation of cell proliferation, the regulation of cell survival, and the regulation of cell differentiation. These interactions make REM1 an attractive target for drug development.

Research on REM1

REM1 has been extensively studied to understand its function and its potential as a drug target. The biology of REM1 has been studied using various techniques, including X-ray crystallography, RNA sequencing, and mass spectrometry.

X-ray crystallography has been used to determine the structure of REM1. The structure of REM1 has been shown to be similar to that of other RAS-like proteins, with a unique fold that is similar to that of the RAS protein.

RNA sequencing has been used to identify the genetic code for REM1. This has allowed researchers to understand the function of REM1 and to identify potential drug targets.

Mass spectrometry has been used to identify the protein components of REM1. This has allowed researchers to understand the structure-activity relationships between the various proteins that make up REM1 and to identify potential drug targets.

Conclusion

In conclusion, REM1 is a protein that plays a critical role in the regulation of various cellular processes. Its unique function as a GAP and its role in the regulation of cellular signaling pathways make it an attractive target for drug development. The biology of REM1 has has been extensively studied using various techniques, including X-ray crystallography, RNA sequencing, and mass spectrometry. Further research is needed to fully understand the function of REM1 and to identify potential drug targets.

Protein Name: RRAD And GEM Like GTPase 1

Functions: Promotes endothelial cell sprouting and actin cytoskeletal reorganization. May be involved in angiogenesis. May function in Ca(2+) signaling

The "REM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about REM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

REM2 | REN | RENBP | REP15 | Repeat-binding factor | REPIN1 | Replication factor C | Replication Protein A Complex (RPA) | REPS1 | REPS2 | RER1 | RERE | REREP3 | RERG | RERGL | RESF1 | RESP18 | REST | RET | Retinoid acid receptor | Retinoid RXR receptor | Retinol dehydrogenase | RETN | RETNLB | RETREG1 | RETREG2 | RETREG3 | RETSAT | REV1 | REV3L | Reverse transcriptase (Telomerase) | REX1BD | REXO1 | REXO1L1P | REXO1L2P | REXO1L6P | REXO1L8P | REXO2 | REXO4 | REXO5 | RFC1 | RFC2 | RFC3 | RFC4 | RFC5 | RFESD | RFESDP1 | RFFL | RFK | RFLNA | RFLNB | RFNG | RFPL1 | RFPL1S | RFPL2 | RFPL3 | RFPL3S | RFPL4A | RFPL4AL1 | RFPL4B | RFT1 | RFTN1 | RFTN2 | RFWD3 | RFX complex | RFX1 | RFX2 | RFX3 | RFX3-DT | RFX4 | RFX5 | RFX5-AS1 | RFX6 | RFX7 | RFX8 | RFXANK | RFXAP | RGCC | RGL1 | RGL2 | RGL3 | RGL4 | RGMA | RGMB | RGMB-AS1 | RGN | RGP1 | RGPD1 | RGPD2 | RGPD3 | RGPD4 | RGPD4-AS1 | RGPD5 | RGPD6 | RGPD8 | RGR | RGS1 | RGS10 | RGS11 | RGS12